Enlivex Therapeutics Ltd. (ENLV) vs Intelligent Bio Solutions Inc. (INBS)
A side-by-side comparison of Enlivex Therapeutics Ltd. and Intelligent Bio Solutions Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENLV
Enlivex Therapeutics Ltd.
$0.35HealthcareDelayed quote: Oct 6, 2026, 1:53 PM EDT
INBS
Intelligent Bio Solutions Inc.
$1.58HealthcareDelayed quote: Oct 6, 2026, 1:52 PM EDT
Total return — ENLV vs INBS
growth of $100 · dividends reinvested · last 6yENLV -99.8% (-63.6%/yr)INBS -100.0% (-80.0%/yr)ENLV compounded faster over this window
Log scale — wide-divergence pair
ENLV INBS
ENLV vs INBS: by the numbers
- •ENLV is the larger company ($6M vs $5M market cap).
- •Both run net losses; ENLV's is the smaller (0.00% vs -294.91% net margin).
Metrics side by side
Valuation
| Metric | ENLV | INBS |
|---|---|---|
| P/E ratio | 0.00 | N/A |
| P/S ratio | N/A | 1.24 |
| P/B ratio | 0.00 | 0.95 |
Profitability
| Metric | ENLV | INBS |
|---|---|---|
| Gross margin | 0.00% | 48.63% |
| Operating margin | 0.00% | -305.03% |
| Net margin | 0.00% | -294.91% |
| ROE | 105.35% | -225.57% |
| ROIC | -0.32% | -179.58% |
Growth (annualized)
| Metric | ENLV | INBS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 19.95% |
| Total return CAGR (5Y) | -69.81% | -80.26% |
Frequently asked
- How have ENLV and INBS total returns compared?
- Over the past 5 years, ENLV delivered -69.81% and INBS delivered -80.26% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Enlivex Therapeutics ROEIntelligent Bio Solutions ROEEnlivex Therapeutics operating marginIntelligent Bio Solutions operating marginEnlivex Therapeutics revenue growthIntelligent Bio Solutions revenue growthEnlivex Therapeutics free cash flowIntelligent Bio Solutions free cash flow
Enlivex Therapeutics & Intelligent Bio Solutions appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.